Results 121 to 130 of about 29,106 (245)

Acoustic modes in M67 cluster stars trace deepening convective envelopes. [PDF]

Nature
Reyes C, Stello D, Ong J, Lindsay C, Hon M, Bedding TR.   +5 more
europepmc   +1 more source

On the main-sequence evolution of massive stars with mass loss [PDF]

, 1984
R. Mitalas, H. J. Falk
openalex   +1 more source

Time, the final frontier

Molecular Oncology, EarlyView.
This article advocates integrating temporal dynamics into cancer research. Rather than relying on static snapshots, researchers should increasingly consider adopting dynamic methods—such as live imaging, temporal omics, and liquid biopsies—to track how tumors evolve over time.
Gautier Follain, Michal Dibus, Omkar Joshi, Guillaume Jacquemet   +3 more
wiley   +1 more source

Subsurface mechanical architecture of coronae on Venus and its implications for processes governing fractures and seismicity. [PDF]

Sci Rep
De Toffoli B, Mazzarini F.
europepmc   +1 more source

Evolution of stars.

The Astronomical Journal, 1952
openaire   +2 more sources

The Evolution of Massive Stars — The Production of Binary WR Stars [PDF]

, 1982
C. De Loore
openalex   +1 more source

Inhibitor of DNA binding‐1 is a key regulator of cancer cell vasculogenic mimicry

Molecular Oncology, EarlyView.
Elevated expression of transcriptional regulator inhibitor of DNA binding 1 (ID1) promoted cancer cell‐mediated vasculogenic mimicry (VM) through regulation of pro‐angiogenic and pro‐cancerous genes (e.g. VE‐cadherin (CDH5), TIE2, MMP9, DKK1). Higher ID1 expression also increased metastases to the lung and the liver.
Emma J. Thompson, Emma L. Dorward, Kristyn Jurrius, Nathalie Nataren, Markus Tondl, Kay K. Myo Min, Michaelia P. Cockshell, Anahita Fouladzadeh, John Toubia, Mark DeNichilo, Delphine Merino, Claudine S. Bonder   +11 more
wiley   +1 more source

Fine-tunings in nucleosynthesis and the emergence of life: status and perspectives. [PDF]

Eur Phys J A Hadron Nucl
Meißner UG, Metsch BC, Meyer H.
europepmc   +1 more source

The evolution of massive close binary stars [PDF]

, 1980
А. В. Тутуков, A.G. Masevich
openalex   +1 more source

MET and NF2 alterations confer primary and early resistance to first‐line alectinib treatment in ALK‐positive non‐small‐cell lung cancer

Molecular Oncology, EarlyView.
Alectinib resistance in ALK+ NSCLC depends on treatment sequence and EML4‐ALK variants. Variant 1 exhibited off‐target resistance after first‐line treatment, while variant 3 and later lines favored on‐target mutations. Early resistance involved off‐target alterations, like MET and NF2, while on‐target mutations emerged with prolonged therapy.
Jie Hu, Ning Ding, Xiaobo Xu, Yedan Chen, Yong Zhang, Jingwen Liu, Jiebai Zhou, Hairong Bao, Donghui Zhang, Yijun Song, Yang Shao, Yuanlin Song   +11 more
wiley   +1 more source